Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01419197
Brief Title: A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy (TH3RESA)

First Submitted : August 16, 2011
First Submitted that Met QC Criteria : August 16, 2011
First Posted : August 18, 2011 (Estimate)

Results First Submitted : February 7, 2014
Results First Submitted that Met QC Criteria : April 3, 2014
Results First Posted : May 5, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : August 17, 2016
Last Update Posted : October 12, 2016 (Estimate)